Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. J of Skin 2020, 4 (6), s124. https://doi.org/10.25251/skin.4.supp.124.